NCT04287387View on ClinicalTrials.gov

Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents

PHASE4UnknownINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

March 2, 2020

Primary Completion Date

March 2, 2021

Study Completion Date

March 2, 2021

Conditions
Type2 Diabetes Mellitus
Interventions
DRUG

Glucophage 500Mg Tablet

0.5g three times daily

DRUG

Acarbose Tablets

50mg three times daily

DRUG

Sitagliptin tablet

100mg once daily

DRUG

Dapagliflozin Tablet

10mg once daily

DRUG

Pioglitazone Tablets

30mg once daily

DRUG

Glimepiride Tablets

2mg once daily

Trial Locations (1)

100730

Peking Union Medical College Hospital, Beijing

Sponsors
All Listed Sponsors
collaborator

Chinese Academy of Sciences

OTHER_GOV

lead

Peking Union Medical College Hospital

OTHER

NCT04287387 - Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents | Biotech Hunter | Biotech Hunter